[HTML][HTML] Achieving the fourth 90: healthy aging for people living with HIV
TG Harris, M Rabkin, WM El-Sadr - Aids, 2018 - journals.lww.com
The availability of potent antiretroviral therapy (ART) has transformed the HIV epidemic,
changing HIV disease from a fatal illness to a chronic, manageable condition. In higher …
changing HIV disease from a fatal illness to a chronic, manageable condition. In higher …
HIV care among elderly population: systematic review and meta-analysis
Elderly people living with HIV are increasing. At present in the United States, nearly half of
newly diagnosed HIV-infected people are aged> 50 years. Diagnosis and treatment of HIV …
newly diagnosed HIV-infected people are aged> 50 years. Diagnosis and treatment of HIV …
[HTML][HTML] Comparison of antiretroviral therapy adherence among HIV-infected older adults with younger adults in Africa: systematic review and meta-analysis
As access to antiretroviral treatment in low-and middle-income countries improves, the
number of older adults (aged≥ 50 years) living with HIV is increasing. This study compares …
number of older adults (aged≥ 50 years) living with HIV is increasing. This study compares …
Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries
EM Frijters, LE Hermans, AMJ Wensing, WLJM Devillé… - Aids, 2020 - journals.lww.com
Methods: PubMed, Embase, Psycinfo and Cochrane were searched for studies that report
on potential risk factors for LTFU in adults who initiated ART in LMICs. Meta-analysis was …
on potential risk factors for LTFU in adults who initiated ART in LMICs. Meta-analysis was …
[HTML][HTML] Retention in care trajectories of HIV-positive individuals participating in a universal test-and-treat program in rural South Africa (ANRS 12249 TasP Trial)
A Gosset, C Protopopescu, J Larmarange… - JAIDS Journal of …, 2019 - journals.lww.com
Objective: To study retention in care (RIC) trajectories and associated factors in patients
eligible for antiretroviral therapy (ART) in a universal test-and-treat setting (TasP trial, South …
eligible for antiretroviral therapy (ART) in a universal test-and-treat setting (TasP trial, South …
[HTML][HTML] Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 …
Summary Background The HPTN 071 (PopART) trial showed that a combination HIV
prevention package including universal HIV testing and treatment (UTT) reduced population …
prevention package including universal HIV testing and treatment (UTT) reduced population …
[PDF][PDF] Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV
TOS ANTIRETROVIRAL - World Health Organization, 2015 - stiftung-gssg.org
WHO first published guidelines on the use of antiretroviral therapy (ART) for HIV infection
among adults and adolescents in 2002 (1) and on the use of antiretroviral (ARV) drugs for …
among adults and adolescents in 2002 (1) and on the use of antiretroviral (ARV) drugs for …
Antiretroviral therapy in older people with HIV
A Richterman, PE Sax - Current Opinion in HIV and AIDS, 2020 - journals.lww.com
Antiretroviral therapy in older people with HIV : Current Opinion in HIV and AIDS Antiretroviral
therapy in older people with HIV : Current Opinion in HIV and AIDS Log in or Register …
therapy in older people with HIV : Current Opinion in HIV and AIDS Log in or Register …
Loss to follow-up trends in HIV-positive patients receiving antiretroviral treatment in Asia from 2003 to 2013
Methods: Analysis included HIV-positive adults initiating ART in 2003–2013 at 7 ART
programs in Asia. Patients LTFU had not attended the clinic for≥ 180 days, had not died, or …
programs in Asia. Patients LTFU had not attended the clinic for≥ 180 days, had not died, or …
The influence of age‐associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV
MY Ahn, A Jiamsakul, S Khusuwan… - Journal of the …, 2019 - Wiley Online Library
Introduction Multiple comorbidities among HIV‐positive individuals may increase the
potential for polypharmacy causing drug‐to‐drug interactions and older individuals with …
potential for polypharmacy causing drug‐to‐drug interactions and older individuals with …